Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: Effects of levothyroxine

Psychiatry Research - Neuroimaging

Volumn 181, Issue 1, 2010, Pages 71-76

  Bauer, Michael ^a,b   Berman, Steven M ^b   Schlagenhauf, Florian ^c   Voytek, Bradley ^b   Rasgon, Natalie ^d   Mandelkern, Mark A ^e   Whybrow, Peter C ^b   London, Edythe D ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Bipolar disorder; Depression; Levothyroxine; Positron emission tomography; Thyroid hormone

Indexed keywords

ANTIDEPRESSANT AGENT; FLUORODEOXYGLUCOSE F 18; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LITHIUM; MOOD STABILIZER; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADJUVANT THERAPY; ADULT; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; INSULA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; SINGLE BLIND PROCEDURE; STATE TRAIT ANXIETY INVENTORY; SUBICULUM; TEMPORAL LOBE; THALAMUS;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; BIPOLAR DISORDER; BRAIN; BRAIN MAPPING; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; THYROXINE; TIME FACTORS;

EID: 71849103993     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2009.07.001     Document Type: Article

References (33)

1. Bauer M., Hellweg R., Gräf K.J., and Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18 (1998) 444-455
2. Bauer M., Berghöfer A., Bschor T., Baumgartner A., Kiesslinger U., Hellweg R., Adli M., Baethge C., and Muller-Oerlinhausen B. Supraphysiological doses of l-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology 27 (2002) 620-628
3. Bauer M., Fairbanks L., Berghöfer A., Hierholzer J., Bschor T., Baethge C., Rasgon N., Sasse J., and Whybrow P.C. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. Journal of Affective Disorders 83 (2004) 183-190
4. Bauer M., London E.D., Rasgon N., Berman S.M., Frye M.A., Altshuler L., Mandelkern M.A., Bramen J., Voytek B., Woods R., Mazziotta J.C., and Whybrow P.C. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in women with bipolar depression. Molecular Psychiatry 10 (2005) 456-469
5. Bauer M., Goetz T., Glenn T., and Whybrow P.C. The thyroid-brain interaction in thyroid disorders and mood disorders. Journal of Neuroendocrinology 20 (2008) 1101-1114
6. Baxter Jr. L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Seli C.E., Gerner R.H., and Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 46 (1989) 243-250
7. Bisaga A., Katz J.L., Antonini A., Wrigh C.E., Margouleff C., Gorman J.M., and Eidelberg D. Cerebral glucose metabolism in women with panic disorder. American Journal of Psychiatry 155 (1998) 1178-1183
8. Charney D.S. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatrica Scandinavica. Supplementum 417 (2003) 38-50
9. Chua P., Krams M., Toni I., Passingham R., and Dolan R. A functional anatomy of anticipatory anxiety. Neuroimage 9 (1999) 563-571
10. Drevets W.C. Neuroimaging studies of mood disorders. Biological Psychiatry 48 (2000) 813-829
11. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., and Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
12. Duvernoy H.M. The human brain. Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply. 2nd ed. (1999), Springer, Vienna
13. Endler N.S., and Kocovski N.L. State and trait anxiety revisited. Journal of Anxiety Disorders 15 (2001) 231-245
14. Frank E., Cyranowski J.M., Rucci P., Shear M.K., Fagiolini A., Thase M.E., Cassano G.B., Grochocinski V.J., Kostelnik B., and Kupfer D.J. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Archives of General Psychiatry 59 (2002) 905-911
15. Freeman M.P., Freeman S.A., and McElroy S.L. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. Journal of Affective Disorders 68 (2002) 1-23
16. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., Willis M.W., Danielson A., Frye M.A., Herscovitch P., and Post R.M. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 49 (2001) 97-109
17. Miller L.A., Taber K.H., Gabbard G.O., and Hurley R.A. Neural underpinnings of fear and its modulation: implications for anxiety disorders. Journal of Neuropsychiatry and Clinical Neuroscience 17 (2005) 1-6
18. Osuch E.A., Ketter T.A., Kimbrell T.A., George M.S., Benson B.E., Willis M.W., Herscovitch P., and Post R.M. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biological Psychiatry 48 (2000) 1020-1023
19. Ramanaiah N.V., Franzen M., and Schill T. A psychometric study of the State-Trait Anxiety Inventory. Journal of Personality Assessment 47 (1983) 531-535
20. Rauch S.L., Savage C.R., Alpert N.M., Fischman A.J., and Jenike M.A. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biological Psychiatry 42 (1997) 446-452
21. Rauch S.L., Shin L.M., and Wright C.I. Neuroimaging studies of amygdala function in anxiety disorders. Annals New York Acad Science 985 (2003) 389-410
22. Rudas S., Schmitz M., Pichler P., and Baumgartner A. Treatment of refractory chronic depression and dysthymia with high-dose thyroxine. Biological Psychiatry 2 (1999) 229-233
23. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., Ohnishi T., Matsuda H., Yasuda A., Sato A., Diksic M., and Kuboki T. Cerebral glucose metabolism associated with a fear network in panic disorder. NeuroReport 16 (2005) 927-931
24. Simon N.M., Otto M.W., Wisniewski S.R., Fossey M., Sagduyu K., Frank E., Sachs G.S., Nierenberg A.A., Thase M.E., and Pollack M.H. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry 161 (2004) 2222-2229
25. Stancer H.C., and Persad E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Archives of General Psychiatry 39 (1982) 311-312
26. Strakowski S.M., Delbello M.P., and Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 10 (2005) 105-116
27. Talairach J., and Tourneoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme, New York
28. Tillfors M., Furmark T., Marteinsdottir I., Fischer H., Pissiota A., Langstrom B., and Fredrikson M. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study. American Journal of Psychiatry 158 (2001) 1220-1226
29. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nature Reviews Neuroscience 6 (2005) 533-544
30. Wellcome Department of Cognitive Neurology, London, UK. Statistical Parametric Mapping (2000). http://www.fil.ion.ucl.ac.uk/spm/ Available at: http://www.fil.ion.ucl.ac.uk/spm/. Accessed 25th January.
31. Whybrow P.C., and Bauer M. Behavioral and psychiatric aspects of thyrotoxicosis. In: Braverman L.E., and Utiger R.D. (Eds). The Thyroid. A Fundamental and Clinical Text, 9th ed. (2005), Lippincott-Raven, Philadelphia 644-650
32. Wittchen H.U., Zhao S., Kessler R.C., and Eaton W.W. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Archives of General Psychiatry 51 (1994) 355-364
33. Woods R.P., Mazziotta J.C., and Cherry S.R. MRI-PET registration with automated algorithm. Journal of Computer Assisted Tomography 17 (1993) 536-546